Healthcare provider profile · identity verified

Cari A Stenz, PA

Physician Assistant · ALPENA, MI · NPI 1548424740

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	333	73
Atorvastatin Calcium	Atorvastatin Calcium	318	85
Omeprazole	Omeprazole	233	61
Losartan Potassium	Losartan Potassium	217	60
Rosuvastatin Calcium	Rosuvastatin Calcium	211	55
Metoprolol Succinate	Metoprolol Succinate	199	52
Lisinopril	Lisinopril	196	51
Famotidine	Famotidine	184	45
Gabapentin	Gabapentin	183	38
Metformin Hcl Er	Metformin Hcl	168	39
Hydrochlorothiazide	Hydrochlorothiazide	136	34
Simvastatin	Simvastatin	136	32
Sertraline Hcl	Sertraline Hcl	124	29
Pantoprazole Sodium	Pantoprazole Sodium	119	32
Furosemide	Furosemide	109	29
Amlodipine Besylate	Amlodipine Besylate	104	26
Fluticasone Propionate	Fluticasone Propionate	99	30
Albuterol Sulfate Hfa	Albuterol Sulfate	93	21
Duloxetine Hcl	Duloxetine Hcl	91	24
Venlafaxine Hcl Er	Venlafaxine Hcl	89	20
Buspirone Hcl	Buspirone Hcl	77	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	77	21
Alendronate Sodium	Alendronate Sodium	76	22
Farxiga	Dapagliflozin Propanediol	73	16
Pregabalin	Pregabalin	70	15
Tamsulosin Hcl	Tamsulosin Hcl	70	14
Metformin Hcl	Metformin Hcl	69	20
Mounjaro	Tirzepatide	66	suppressed
Alprazolam	Alprazolam	63	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	17
Metoprolol Tartrate	Metoprolol Tartrate	61	15
Glimepiride	Glimepiride	58	14
Celecoxib	Celecoxib	54	18
Allopurinol	Allopurinol	53	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	19
Carvedilol	Carvedilol	52	suppressed
Montelukast Sodium	Montelukast Sodium	52	16
Fluoxetine Hcl	Fluoxetine Hcl	49	12
Glipizide Er	Glipizide	48	12
Trazodone Hcl	Trazodone Hcl	48	12
Citalopram Hbr	Citalopram Hydrobromide	46	12
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Ezetimibe	Ezetimibe	41	12
Meloxicam	Meloxicam	41	12
Eliquis	Apixaban	40	suppressed
Ibandronate Sodium	Ibandronate Sodium	40	suppressed
Lovastatin	Lovastatin	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	13
Potassium Chloride	Potassium Chloride	39	12
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Enalapril Maleate	Enalapril Maleate	35	suppressed
Myrbetriq	Mirabegron	34	suppressed
Topiramate	Topiramate	32	suppressed
Jardiance	Empagliflozin	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	28	suppressed
Estradiol	Estradiol	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	18
Nystatin	Nystatin	24	18
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Fluconazole	Fluconazole	21	17
Mirtazapine	Mirtazapine	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Methadone Hcl	Methadone Hcl	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Atenolol	Atenolol	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Ozempic	Semaglutide	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Azelastine Hcl	Azelastine Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Bydureon Bcise	Exenatide Microspheres	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Finasteride	Finasteride	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Invokana	Canagliflozin	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Pen Needles	Pen Needle, Diabetic	13	suppressed
Prevacid	Lansoprazole	13	suppressed
Valsartan	Valsartan	13	suppressed
Baclofen	Baclofen	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Dicloxacillin Sodium	Dicloxacillin Sodium	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error